Edward van der Horst

Insider Reports History

Entity
Individual
Location
C/O Sensei Biotherapeutics, Inc., 451 D Street, Suite 710, Boston, MA
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Edward van der Horst:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sensei Biotherapeutics, Inc. CHIEF SCIENTIFIC OFFICER Common Stock 59.8K $28.5K $0.48 Feb 19, 2025 Direct
Sensei Biotherapeutics, Inc. CHIEF SCIENTIFIC OFFICER Stock Option (Right to Buy) 110K Feb 14, 2025 Direct

Insider Reports Filed by Edward van der Horst

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNSE Sensei Biotherapeutics, Inc. Feb 19, 2025 1 -$1.08K 4 Feb 26, 2025 CHIEF SCIENTIFIC OFFICER
SNSE Sensei Biotherapeutics, Inc. Feb 14, 2025 1 $0 4 Feb 14, 2025 CHIEF SCIENTIFIC OFFICER
SNSE Sensei Biotherapeutics, Inc. Dec 20, 2024 1 $0 4 Dec 23, 2024 CHIEF SCIENTIFIC OFFICER
SNSE Sensei Biotherapeutics, Inc. Feb 15, 2024 3 -$2.25K 4 Feb 16, 2024 CHIEF SCIENTIFIC OFFICER
SNSE Sensei Biotherapeutics, Inc. Feb 15, 2023 1 -$14.3K 4 Sep 11, 2023 Chief Scientific Officer
SNSE Sensei Biotherapeutics, Inc. Feb 15, 2023 3 $0 4 Feb 17, 2023 Chief Scientific Officer
SNSE Sensei Biotherapeutics, Inc. Dec 7, 2022 0 $0 3 Dec 16, 2022 Chief Scientific Officer